195 related articles for article (PubMed ID: 21665938)
1. Fibroblast growth factor receptor mediates fibroblast-dependent growth in EMMPRIN-depleted head and neck cancer tumor cells.
Liu Z; Hartman YE; Warram JM; Knowles JA; Sweeny L; Zhou T; Rosenthal EL
Mol Cancer Res; 2011 Aug; 9(8):1008-17. PubMed ID: 21665938
[TBL] [Abstract][Full Text] [Related]
2. Modulation of tumor cell growth in vivo by extracellular matrix metalloprotease inducer.
Newman JR; Bohannon IA; Zhang W; Skipper JB; Grizzle WE; Rosenthal EL
Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1218-24. PubMed ID: 19015455
[TBL] [Abstract][Full Text] [Related]
3. Combined inhibition of EMMPRIN and epidermal growth factor receptor prevents the growth and migration of head and neck squamous cell carcinoma cells.
Suzuki S; Ishikawa K
Int J Oncol; 2014 Mar; 44(3):912-7. PubMed ID: 24379084
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of EMMPRIN isoform 2 is associated with head and neck cancer metastasis.
Huang Z; Tan N; Guo W; Wang L; Li H; Zhang T; Liu X; Xu Q; Li J; Guo Z
PLoS One; 2014; 9(4):e91596. PubMed ID: 24705283
[TBL] [Abstract][Full Text] [Related]
5. Extracellular matrix metalloprotease inducer stimulates fibroblast-mediated tumor growth in vivo.
Rosenthal EL; Vidrine DM; Zhang W
Laryngoscope; 2006 Jul; 116(7):1086-92. PubMed ID: 16826041
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of fibroblasts reduced head and neck cancer growth by targeting fibroblast growth factor receptor.
Sweeny L; Liu Z; Lancaster W; Hart J; Hartman YE; Rosenthal EL
Laryngoscope; 2012 Jul; 122(7):1539-44. PubMed ID: 22460537
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor receptors are components of autocrine signaling networks in head and neck squamous cell carcinoma cells.
Marshall ME; Hinz TK; Kono SA; Singleton KR; Bichon B; Ware KE; Marek L; Frederick BA; Raben D; Heasley LE
Clin Cancer Res; 2011 Aug; 17(15):5016-25. PubMed ID: 21673064
[TBL] [Abstract][Full Text] [Related]
8. Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancer.
Dean NR; Newman JR; Helman EE; Zhang W; Safavy S; Weeks DM; Cunningham M; Snyder LA; Tang Y; Yan L; McNally LR; Buchsbaum DJ; Rosenthal EL
Clin Cancer Res; 2009 Jun; 15(12):4058-65. PubMed ID: 19509148
[TBL] [Abstract][Full Text] [Related]
9. EMMPRIN expression is required for response to bevacizumab therapy in HNSCC xenografts.
Newman JR; Helman EE; Safavy S; Zhang W; Rosenthal EL
Cancer Lett; 2009 Feb; 274(2):313-8. PubMed ID: 18990485
[TBL] [Abstract][Full Text] [Related]
10. Highly expressed tumoral emmprin and stromal CD73 predict a poor prognosis for external auditory canal carcinoma.
Miyazaki M; Aoki M; Okado Y; Koga K; Hamasaki M; Nakagawa T; Sakata T; Nabeshima K
Cancer Sci; 2020 Aug; 111(8):3045-3056. PubMed ID: 32473077
[TBL] [Abstract][Full Text] [Related]
11. Extracellular matrix metalloprotease inducer-expressing head and neck squamous cell carcinoma cells promote fibroblast-mediated type I collagen degradation in vitro.
Rosenthal EL; Zhang W; Talbert M; Raisch KP; Peters GE
Mol Cancer Res; 2005 Apr; 3(4):195-202. PubMed ID: 15831673
[TBL] [Abstract][Full Text] [Related]
12. Effect of FGF/FGFR pathway blocking on lung adenocarcinoma and its cancer-associated fibroblasts.
Hegab AE; Ozaki M; Kameyama N; Gao J; Kagawa S; Yasuda H; Soejima K; Yin Y; Guzy RD; Nakamura Y; Ornitz DM; Betsuyaku T
J Pathol; 2019 Oct; 249(2):193-205. PubMed ID: 31090071
[TBL] [Abstract][Full Text] [Related]
13. Separation of cell survival, growth, migration, and mesenchymal transdifferentiation effects of fibroblast secretome on tumor cells of head and neck squamous cell carcinoma.
Metzler VM; Pritz C; Riml A; Romani A; Tuertscher R; Steinbichler T; Dejaco D; Riechelmann H; Dudás J
Tumour Biol; 2017 Nov; 39(11):1010428317705507. PubMed ID: 29157176
[TBL] [Abstract][Full Text] [Related]
14. Cyclophilin A-EMMPRIN interaction induces invasion of head and neck squamous cell carcinoma.
Takahashi M; Suzuki S; Ishikawa K
Oncol Rep; 2012 Jan; 27(1):198-203. PubMed ID: 21956400
[TBL] [Abstract][Full Text] [Related]
15. Differential roles of fibroblast growth factor receptors (FGFR) 1, 2 and 3 in the regulation of S115 breast cancer cell growth.
Tarkkonen KM; Nilsson EM; Kähkönen TE; Dey JH; Heikkilä JE; Tuomela JM; Liu Q; Hynes NE; Härkönen PL
PLoS One; 2012; 7(11):e49970. PubMed ID: 23185502
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor receptor 3-mediated reactivation of ERK signaling promotes head and neck squamous cancer cell insensitivity to MEK inhibition.
Ban MJ; Byeon HK; Yang YJ; An S; Kim JW; Kim JH; Kim DH; Yang J; Kee H; Koh YW
Cancer Sci; 2018 Dec; 109(12):3816-3825. PubMed ID: 30343534
[TBL] [Abstract][Full Text] [Related]
17. Translocation of Exogenous FGF1 and FGF2 Protects the Cell against Apoptosis Independently of Receptor Activation.
Kostas M; Lampart A; Bober J; Wiedlocha A; Tomala J; Krowarsch D; Otlewski J; Zakrzewska M
J Mol Biol; 2018 Oct; 430(21):4087-4101. PubMed ID: 30099027
[TBL] [Abstract][Full Text] [Related]
18. FGF signaling in mammary gland fibroblasts regulates multiple fibroblast functions and mammary epithelial morphogenesis.
Sumbal J; Koledova Z
Development; 2019 Dec; 146(23):. PubMed ID: 31699800
[TBL] [Abstract][Full Text] [Related]
19. EMMPRIN regulates tumor growth and metastasis by recruiting bone marrow-derived cells through paracrine signaling of SDF-1 and VEGF.
Chen Y; Gou X; Kong DK; Wang X; Wang J; Chen Z; Huang C; Zhou J
Oncotarget; 2015 Oct; 6(32):32575-85. PubMed ID: 26416452
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of TGF-beta1 in head and neck cancer-associated fibroblasts.
Rosenthal E; McCrory A; Talbert M; Young G; Murphy-Ullrich J; Gladson C
Mol Carcinog; 2004 Jun; 40(2):116-21. PubMed ID: 15170816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
